ONCOLYTICS BIOTECH INC.: cashflow_investing
| Value | {"amount": -6000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2026-01-01 – 2026-06-30 |
| Status | current |
| Entity | ONCOLYTICS BIOTECH INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:20:03.381402+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ccc73443-830a-4cf5-9bc3-9e9ecc66e80b
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001129928-26-000051 · Open the official SEC filing →Retrieved: 2026-08-19T11:20:03.381402+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001129928/cashflow-investing/2026-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ccc73443-830a-4cf5-9bc3-9e9ecc66e80b
History
- no predecessors — first report